Inventory decreased 19.9%
Inventory changed -19.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed -19.9% from the comparable as-filed period.
Capex / revenue changed +162 basis points from the comparable as-filed period.
Capital expenditure changed +92.3% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Debt changed -99.2% from the comparable as-filed period.
Free-cash-flow proxy changed +328.6% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
Net income changed +30.2% from the comparable as-filed period.
Operating cash flow changed +1012.5% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Gross margin changed +203 basis points from the comparable as-filed period.
Cash & equivalents changed -11.6% from the comparable as-filed period.
Operating income changed +6.2% from the comparable as-filed period.
Stock-based compensation changed -7.1% from the comparable as-filed period.
Gross profit changed -0.4% from the comparable as-filed period.
Operating margin changed +20 basis points from the comparable as-filed period.
Revenue changed -3.5% from the comparable as-filed period.
Selling, general & administrative changed -0.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.